Responses
Original Articles
Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.